SCHEMBL16169461

SCHEMBL16169461

CC(C)c1cc2cc3ccccc3cc2cc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.50
GABRB2 P47870 2/20 0.50
LMNA P02545 3/20 0.45
SLC6A2 P23975 2/20 0.45
HTR2B P41595 2/20 0.45
TRPA1 O75762 1/20 0.45
CHRM1 P11229 1/20 0.45
ADRA1A P35348 1/20 0.45
UGT2B7 P16662 1/20 0.44
CYP1A2 P05177 4/20 0.42
CYP3A4 P08684 3/20 0.42
MAPT P10636 3/20 0.42
CYP2C19 P33261 2/20 0.42
GAA P10253 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
HSP90AA1 P07900 4/20 0.41
HIF1A Q16665 2/20 0.41
FAAH O00519 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6400171 0.96 GABRA1 (0.54) GABRA1GABRB2LMNASLC6A2HTR2B
SCHEMBL10331781 0.82 CYP1A2 (0.50) GABRA1GABRB2LMNASLC6A2HTR2B
SCHEMBL22214043 0.82 CYP1A2 (0.50) GABRA1GABRB2LMNASLC6A2HTR2B
SCHEMBL24925045 0.81 HTR2A (0.51) HTR2BCYP1A2HTR2CALOX5
SCHEMBL8897330 0.80 TRPA1 (0.47) GABRA1GABRB2LMNASLC6A2HTR2B
SCHEMBL17707911 0.80 TRPA1 (0.47) GABRA1GABRB2LMNASLC6A2HTR2B
SCHEMBL6403723 0.79 TYR (0.49) GABRA1GABRB2SLC6A2UGT2B7CYP1A2
SCHEMBL29387216 0.79 UGT2B7 (0.50) GABRA1GABRB2LMNASLC6A2HTR2B
SCHEMBL19997121 0.79 GABRA1 (0.40) GABRA1GABRB2LMNASLC6A2HTR2B
SCHEMBL28050435 0.79 CYP2A6 (0.47) GABRA1GABRB2LMNASLC6A2HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9636656-B2 Caged compound delivery and related compositions, methods and systems CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-05-02 US disclosed
US-20140311890-A1 PHOTOACID COMPOUNDS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS CALIFORNIA INSTITUTE OF TECHNOLOGY 2014-10-23 US disclosed
US-20140308208-A1 CAGED COMPOUND DELIVERY AND RELATED COMPOSITIONS, METHODS AND SYSTEMS CALIFORNIA INSTITUTE OF TECHNOLOGY 2014-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140308208-A1 CAGED COMPOUND DELIVERY AND RELATED COMPOSITIONS, METHODS AND SYSTEMS VIP, CRH, STRA6 GABRA1 3153/4885GABRB2 2511/4885LMNA 816/4885
US-20140311890-A1 PHOTOACID COMPOUNDS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS PAM, PPOX, HCCS GABRA1 1807/4885GABRB2 2005/4885LMNA 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.